Author:
Park Seungju,Lee Kyung Hwa,Ko Beomseok,Kim Namkug
Abstract
AbstractBreast cancer is a common cancer among women, and screening mammography is the primary tool for diagnosing this condition. Recent advancements in deep-learning technologies have triggered the implementation of research studies via mammography. Semi-supervised or unsupervised methods are often used to overcome the limitations of supervised learning, such as manpower and time, for labeling in clinical situations where abnormal data are significantly lacking. Accordingly, we proposed a generative model that uses a state-of-the-art generative network (StyleGAN2) to create high-quality synthetic mammographic images and an anomaly detection method to detect breast cancer on mammograms in unsupervised methods. The generation model was trained via only normal mammograms and breast cancer classification was performed via anomaly detection using 50 breast cancer and 50 normal mammograms that did not overlap with the dataset for generative model learning. Our generative model has shown comparable fidelity to real images, and the anomaly detection method via this generative model showed high sensitivity, demonstrating its potential for breast cancer screening. This method could differentiate between normal and cancer-positive mammogram and help overcome the weakness of current supervised methods.
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Ghoncheh, M., Pournamdar, Z. & Salehiniya, H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac. J. Cancer Prev. 17(3), 43–46 (2016).
2. Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209–249 (2021).
3. Fletcher, S. W. et al. Report of the international workshop on screening for breast cancer. J. Natl. Cancer Inst. 85(20), 1644–1656 (1993).
4. Chu, K. C., Smart, C. R. & Tarone, R. E. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J. Natl. Cancer Inst. 80(14), 1125–1132 (1988).
5. Miller, A. B. et al. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 147(10), 1459 (1992).
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献